Melior Discovery Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Private

  • Employees
  • 24

Employees

  • Latest Deal Type
  • Debt - PPP

  • Latest Deal Amount
  • $294K

  • Investors
  • 11

Melior Discovery General Information

Description

Developer of in vivo pharmacology intended to identify indications for pre-clinical and development-stage drug candidates. The company specializes in offering rapid and cost-effective identification of new therapeutic potential by systematically screening candidates in a diverse array of validated in vivo disease models, enabling clients to get bioanalytical testing products.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 860 Springdale Drive
  • Suite 500
  • Exton, PA 19341
  • United States
+1 (610)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 860 Springdale Drive
  • Suite 500
  • Exton, PA 19341
  • United States
+1 (610)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Melior Discovery Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Debt - PPP 13-Apr-2020 $294K Completed Generating Revenue
8. Grant 11-Dec-2014 Completed Generating Revenue
7. Later Stage VC 06-Feb-2013 Completed Generating Revenue
6. Later Stage VC (Series A) 07-Oct-2011 Completed Generating Revenue
5. Grant 16-Aug-2011 Completed Generating Revenue
4. Early Stage VC (Series B) 23-Sep-2009 Completed Generating Revenue
3. Early Stage VC (Series A) 19-Jun-2007 Completed Startup
2. Early Stage VC (Series A) 01-Apr-2006 $2.5M $3M Completed Startup
1. Seed Round 25-Jan-2005 $500K $500K Completed Startup
To view Melior Discovery’s complete valuation and funding history, request access »

Melior Discovery Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
To view Melior Discovery’s complete cap table history, request access »

Melior Discovery Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of in vivo pharmacology intended to identify indications for pre-clinical and development-stage drug candidate
Drug Discovery
Exton, PA
24 As of 2025

Frederick, MD
 

Paramus, NJ
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Melior Discovery Competitors (6)

One of Melior Discovery’s 6 competitors is StageBio, a Private Equity-Backed company based in Frederick, MD.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
StageBio Private Equity-Backed Frederick, MD
Psychogenics Private Debt Financed Paramus, NJ
Alturas Analytics Corporation Moscow, ID
Empire Genomics Formerly PE-Backed Depew, NY
HistologiX Corporate Backed or Acquired Nottingham, United Kingdom
To view Melior Discovery’s complete competitors history, request access »

Melior Discovery Patents

Melior Discovery Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220031700-A1 Treatment of acute respiratory distress syndrome (ards) Inactive 30-Jul-2020
WO-2022026645-A1 Treatment of acute respiratory distress syndrome (ards) Inactive 30-Jul-2020
AU-2019223911-A1 Treatment of liver diseases Inactive 21-Feb-2018
CA-3088178-A1 Treatment of liver diseases Pending 21-Feb-2018
EP-3755334-A1 Treatment of liver diseases Inactive 21-Feb-2018 A61K31/513
To view Melior Discovery’s complete patent history, request access »

Melior Discovery Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Melior Discovery Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institute of Diabetes and Digestive and Kidney Diseases Government
Angel (individual) Minority
EarlyStage.nyc Fund Venture Capital Minority
Angel (individual) Minority
Michael J. Fox Foundation Limited Partner
You’re viewing 5 of 11 investors. Get the full list »

Melior Discovery Acquisitions (1)

Melior Discovery’s most recent deal was a Merger/Acquisition with Biolucidation. The deal was made on 09-Jul-2013.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Biolucidation 09-Jul-2013 Merger/Acquisition Other Pharmaceuticals and Biotechnology
To view Melior Discovery’s complete acquisitions history, request access »

Melior Discovery FAQs

  • When was Melior Discovery founded?

    Melior Discovery was founded in 2005.

  • Where is Melior Discovery headquartered?

    Melior Discovery is headquartered in Exton, PA.

  • What is the size of Melior Discovery?

    Melior Discovery has 24 total employees.

  • What industry is Melior Discovery in?

    Melior Discovery’s primary industry is Drug Discovery.

  • Is Melior Discovery a private or public company?

    Melior Discovery is a Private company.

  • What is Melior Discovery’s current revenue?

    The current revenue for Melior Discovery is .

  • How much funding has Melior Discovery raised over time?

    Melior Discovery has raised $8.69M.

  • Who are Melior Discovery’s investors?

    National Institute of Diabetes and Digestive and Kidney Diseases, , EarlyStage.nyc Fund, , and Michael J. Fox Foundation are 5 of 11 investors who have invested in Melior Discovery.

  • Who are Melior Discovery’s competitors?

    StageBio, Psychogenics, Alturas Analytics, Empire Genomics, and HistologiX are some of the 6 competitors of Melior Discovery.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process